Tadalafil 5 mg + Placebo tablet + Tamsulosin + Placebo capsule
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Benign Prostatic Hyperplasia (BPH)
Conditions
Benign Prostatic Hyperplasia (BPH)
Trial Timeline
Oct 1, 2009 → Jan 1, 2011
NCT ID
NCT00970632About Tadalafil 5 mg + Placebo tablet + Tamsulosin + Placebo capsule
Tadalafil 5 mg + Placebo tablet + Tamsulosin + Placebo capsule is a phase 3 stage product being developed by Eli Lilly for Benign Prostatic Hyperplasia (BPH). The current trial status is completed. This product is registered under clinical trial identifier NCT00970632. Target conditions include Benign Prostatic Hyperplasia (BPH).
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00970632 | Phase 3 | Completed |
Competing Products
20 competing products in Benign Prostatic Hyperplasia (BPH)